H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares traded.
H. Lundbeck A/S Price Performance
The company’s fifty day simple moving average is $22.00 and its two-hundred day simple moving average is $22.00. The stock has a market capitalization of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.71 and a current ratio of 1.15.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Articles
- Five stocks we like better than H. Lundbeck A/S
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- The Significance of Brokerage Rankings in Stock Selection
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Are Penny Stocks a Good Fit for Your Portfolio?
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.